Antihemophilic Factor (Recombinant [Pegylated-aucl]) and Ciprofloxacin Tablets
Determining the interaction of Antihemophilic Factor (Recombinant [Pegylated-aucl]) and Ciprofloxacin Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
Generic Name: ciprofloxacin
Brand name: Cipro, Cipro XR, Proquin XR, Cipro IV
Synonyms: Ciprofloxacin, Ciprofloxacin (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Antihemophilic Factor (Recombinant [Pegylated-aucl])-Cisapride Suspension
- Antihemophilic Factor (Recombinant [Pegylated-aucl])-Cisapride Tablets
- Antihemophilic Factor (Recombinant [Pegylated-aucl])-Cisatracurium
- Antihemophilic Factor (Recombinant [Pegylated-aucl])-Cisatracurium Besylate
- Antihemophilic Factor (Recombinant [Pegylated-aucl])-Cisatracurium Besylate Injection
- Antihemophilic Factor (Recombinant [Pegylated-aucl])-Cisatracurium besylate Intravenous
- Ciprofloxacin Tablets-Antihemophilic Factor (Recombinant [Pegylated])
- Ciprofloxacin Tablets-Antihemophilic Factor (Recombinant [Pegylated]) Injection
- Ciprofloxacin Tablets-Antihemophilic Factor (Recombinant [Porcine Sequence])
- Ciprofloxacin Tablets-Antihemophilic Factor (Recombinant) (Advate)
- Ciprofloxacin Tablets-Antihemophilic Factor (Recombinant) (Afstyla)
- Ciprofloxacin Tablets-Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS)